Novo holdings fund size dk CVR# 24257630 The fund is launched with support from a strong investor syndicate comprising Saminvest, the European Investment Fund (EIF), Vækstfonden, Novo Holdings, as well as additional private investors. Novo Holdings A/S (formerly Novo A/S) is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. dk. Copenhagen, Denmark Through its Seeds, Venture, Growth, and Principal Investments teams, Novo Holdings invests in life science companies at all stages of Novo Holdings A/S. Capital Investments: Management of a diverse portfolio including equities, bonds, real estate, and infrastructure to generate long-term *Novo Ventures (US) Inc. Between 2020 and 2023, Gaugler was a partner and head of investment strategy at medical technology specialist Endeavour Vision, as per her LinkedIn profile. Seed Investments Venture Investments Growth Investments Principal Investments Planetary Health Investments. Christian Mostrup Scheel. (JJDC), joined by existing investors Boehringer Ingelheim *Novo Ventures (US) Inc. Novo Holdings first invested in Minervax in 2014 and remains its largest shareholder. The fund is located in Copenhagen, Denmark. 31 mia. Fund Finances Novo Holdings commits DKK 1. With over 1,500 employees in offices around the world, including Copenhagen, Boston, San Francisco, London, and Hong Kong, the organization is one of the largest life science investors globally. af CHRISTIAN BUNDGAARD. Size: Address: 51-200 employees; Tuborg Havnevej 19, 2900 Hellerup, Denmark; Novo Holdings It is crucial for the pension fund to enter partnerships with other professional investors who share PKA’s view that there is an urgent need for long-term investments in a more sustainable future. are separate legal *Novo Ventures (US) Inc. Fund Structure Closed Size (MN) Target Size (MN) Primary Region Focus; Venture (General) Closed: Commingled: Novo Holdings established the REPAIR Impact Fund commissioned by the Novo Nordisk Foundation in February 2018 with a total budget of USD 165 million to invest in companies involved in discovering and the early-stage development of therapies targeting resistant microorganisms. Strong Investment Portfolio performance, and growth of the Novo Group companies Prior to this, Nigel held Director positions in EQT Fund Management Limited and EQT Partners UK, 2010-2014, and in Close Brothers including the role as Chief Operating Officer and Head of Fund Management (2007-2009). Strategy 2021. Through its Seeds, Venture, Growth, Asia, Bioindustrial and Principal Investments teams, Novo Holdings invests in life science companies at all stages of development. are separate legal entities that provide The new ISQ Global Infrastructure Fund III fund aims to raise DKK 76 billion (USD 12 billion) for infrastructure investments in the United States, Europe, Asia and Latin America. Life Science. Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Copenhagen, Denmark-based Novo Holdings announced that it has agreed to acquire Benchmark Genetics, a Bergen, Norway-based fish genetics company, from Benchmark Holdings plc for an enterprise Mubadala has a portfolio spanning six continents and valued at $276 billion. 4 billion) in 2022. Novo Nordisk har nu samlede værdier for 1114 mia. , Novo Holdings is a world-leading life science investor with offices in Copenhagen, London, Boston, San Francisco, Singapore, and Shanghai. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech Novo Holdings A/S. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech Novo Holdings co-led the financing with Boehringer Ingelheim Venture Fund and Industrifonden. Novo *Novo Ventures (US) Inc. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly View Top Holdings and Key Holding Information for Precidian ETFs Trust Novo Nordi (NVOH). San Francisco: One Market Plaza, Floor 17 of the Steuart Tower. Novo Holdings | 58. This fund was announced on Feb 28, 2018 and raised a total of Leverage validated data, identify key contacts and secure funding opportunities for your business. We invest in the US, Europe and Asia, across the life sciences continuum from very early-stage Seed investments, through the Growth Investments Planetary Health Investments Asia Investments Venture Investments Seed *Novo Ventures (US) Inc. dk CVR# 24257630 Indian PE fund on first Nordic roadshow: "A 25% return is coming out of fundamental business growth" India’s quasi-sovereign NIIF is raising capital for a new PE fund of funds. Investing to benefit people and the planet | Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation, one of the world’s largest philanthropic enterprise foundations. Prior to this, he worked at the growth equity fund Verdane and corporate finance advisor Oaklins. The funding will be used to accelerate growth and to partly fund the acquisition of Asian Healthcare Specialists. North America Europe Asia. Copenhagen, Denmark, 24 January 2023 – Seed Investments, the early stage investment and company creation team of Novo CAMBRIDGE, Mass. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly *Novo Ventures (US) Inc. Responsibility. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech Following Nordic Capital’s initial investment in ERT through Fund VIII, Nordic Capital will re-invest alongside Astorg and Novo through Fund IX. Start Free Trial . dk CVR# 24257630 Board member warfair and Global Bio Fund. Novo Nordisk's A shares are not listed and are held by Novo Holdings A/S, a Danish public limited liability company wholly owned by the Novo Novo Holdings - Private equity and venture capital fund focused on the healthcare sector. 2019 IN BRIEF 3 125 100 75 50 25 0 DKK Novo Holdings A/S. From 1986 to 1988, Jeppe Christiansen worked as an economist in Sparekassen SDS. The company also expects to expand its portfolio of oncology-related tests beyond prostate cancer and into additional indications like breast Novo Holdings is a world-leading life science investor with offices in Copenhagen, London, Boston, San Francisco, Singapore, and Shanghai. 5 billion. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech · Established the Novo Holdings Bioindustrial Investments team, now overseeing a dynamic portfolio of 23 companies. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various Novo Holdings is a world-leading life science investor with a focus on creating long-term value. · Made substantial investments, solidifying Novo Holdings’ position as one of the world's foremost active investors in the bioindustrial sector. 4 billion). Novo Holdings currently intends to maintain its ownership of around 28% of Novo Nordisk share capital. 2 Copenhagen, Denmark – Novo Holdings, a leading international life sciences investor, today announces it has led the £11million Series A financing in Roslin Technologies Ltd (Roslin Tech), an Edinburgh-based food & ag tech company. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech Novo Holdings, through its US subsidiary, has committed up to $25 million over a five-year period to fund seed-stage drug discovery projects at Broad, spanning a wide range of indications and therapeutic modalities. The com Novo Holdings invests in life science companies at all stages of development and, in addition, manages a broad portfolio of equities, bonds, real estate and infrastructure assets as well as Novo Nordisk ownership structure and the difference of A and B shares. Responsibility Novo Nordisk Foundation. Areas. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various The Fund has now invested a total of USD 30 million in six companies. Prior to that, she managed public equity funds at Lombard Odier Investment Managers and was a partner in Endeavour Vision, a healthcare venture fund in Switzerland. dk www Novo Holdings invests in biotech across all stages through its different venture, growth and capital funds. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the This partnership with Novo Holdings REPAIR Impact Fund will prove invaluable in advancing our efforts of delivering a new innovative class of preventive medicines to combat staphylococcal infections Novo Holdings US Inc. Copenhagen, Denmark – Novo Holdings today announced its financial results for 2022, with a negative -6% return on the Investment Portfolio and Total Income and Returns of DKK 3 billion (€0. Maurits holds a BSc in Chemistry and an MSc in Molecular Biology, both from Leiden University. Novo Holdings’ efforts to combat antimicrobial resistance (AMR) include a $165 million investment in the Replenishing and Enabling the Pipeline for Anti-Infective Resistance (REPAIR) Fund, which supports startups and The Series A financing round was co-led by Adjuvant Capital, AXA IM Alts and the Novo Holdings REPAIR Impact Fund. Need more data? Get access to full data about investors, including their team, contact Copenhagen, Denmark – Novo Holdings today announced its financial results for 2023*. dk CVR# 24257630 REPAIR Impact Fund making strides in the vital combat against Antimicrobial Resistance. The REPAIR (Replenishing and Enabling the Pipeline for Anti-Infective Resistance) Impact Fund invests in companies involved in discovering and early-stage development of therapies targeting resistant microorganisms. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech Værdien af Novo Holdings' samlede aktiver vokser tocifret i 2023 Der blev i alt budt velkommen til 30 nye selskaber i porteføljen i 2023, mens Novo Holdings lavede 26 exits. Novo Holdings today announced its financial results for 2023*. , comprising Novo *Novo Ventures (US) Inc. | Foto: Novo Holdings / Pr. However, developing these Fund Portfolio Manager Performance 24Q3 AUM # of Holdings Performance Rank Allocation ; Novo Holdings A S: Novo Holdings A S: 17. Preqin Pro Alternative assets data platform. Novo Holdings is a long-term investor with the Investment Portfolio comprising Life Science Investments (52% of the portfolio) and Capital Investments (48% of the portfolio). 2900 Hellerup Denmark Inc. , comprising Novo Growth and Principal Investments, and Novo Holdings Denmark’s Export and Investment Fund is among the existing investors and has been investing in Evosep since 2016. About Novo Group Leadership Responsibility Novo Nordisk Foundation. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech Novo Holdings is a world-leading life science investor with a focus on creating long-term value. CVR# 24257630. Novo Holdings US Inc. Furthermore, we plan to participate in the share repurchase programme of Novozymes. COPENHAGEN, Denmark, BOSTON, Mass. Copenhagen, Denmark, 21 April 2022 – Novo Growth, the growth-stage investment arm of Novo Holdings, today publishes its annual newsletter. 2900 Hellerup Denmark +45 3527 6500 Novo Holdings US Inc. dk CVR# 24257630 6 billion. Sound Bioventures is a specialist life sciences venture capital fund investing in about-to-be clinical or clinical stage private companies in Europe and the USA developing therapeutics in areas of significant clinical unmet need. The round was led by Boehringer Ingelheim Venture Fund GmbH (BIVF) and Novo Seeds, and complemented by the High-Tech Gruenderfonds and coparion. 2900 Hellerup Denmark +45 3527 6500 . are separate legal entities that Novo Holdings realized record Income and Investment Returns of DKK 29 billion in 2020, up from DKK 26 billion in 2019. www. AMWatch has interviewed Anand Unnikrishnan, Novo Holdings is a world-leading life science investor with a focus on creating long-term value. Prior to joining Novo Holdings, Aleks was employed as VP in Baxter International in Illinois and Shanghai, working with global M&A licensing, Use Private Equity International's platform to access the latest news, analysis, insights and fund data for Novo Holdings A/S, as well as key contact information. 4%, compared to -6. News & Reports Today the Novo Holdings REPAIR Impact Fund announces that three additional investments were made in late 2018. 4 billion); Total Assets are reported at DKK 805 billion Novo Holdings Partner, Morten Graugaard, to lead Orbis as CEO Macrocycles are a large and diverse family of compounds with highly desirable therapeutic properties. , Sept. 1 billion in four companies, taking its total portfolio to 10 companies. Novo Holdings A/S. Novo Holdings owns more than 25% of the ordinary share capital of the companies, including all the preferred (A) shares, and more than 70% of the votes. a Copenhagen based infrastructure fund. Capital Investments. Novo Holdings A/S The REPAIR Impact Fund is a Novo Holdings initiative. Novo Holdings Novo Holdings A/S. are separate legal entities that provide certain consultancy Novo Holdings US Inc. Based in Copenhagen and London, Glentra is a newly established Novo Holdings isn’t a corporate venture fund. Ltd. , comprising Novo Growth and Principal Aleks also leads Novo Holdings’ REPAIR Impact Fund targeting antimicrobial resistance. Novo Holdings will play a central role in helping to further build Booster in its next phase of growth, bringing hands-on operational expertise, strategic Meret started her engagement as a Partner-at-Large in the Growth Investments team of Novo Holdings in August 2024. are separate legal entities that provide Novo Holdings is a world-leading life science investor with a focus on creating long-term value. , comprising Novo Growth and Principal Investments, and The proceeds will accelerate the commercial strategy of the company’s protein-centric test, IsoPSA, fund expanded infrastructure and R&D pipeline development, and broaden the geographic scope of its prostate cancer test. novoholdings. During her 6 year tenure with the firm, she worked on numerous healthcare, health-tech and life sciences investments in India and was actively involved across deal evaluation and execution, portfolio monitoring, exits and fund raising. San Francisco, CA 94105 USA +1 (415) 552-6686. kr. In just two years, DKK 1 billion in US-based infrastructure fund I Squared Capital. Copenhagen, Denmark – Novo Holdings A/S, a leading global life sciences investor, today announces a significant investment in HPNow, a Danish firm pioneering an innovative form of water treatment, alongside the Export and Investment Fund of Denmark (EIFO) and existing investors MatiTech, Evonik Venture Capital and AP Ventures. Daniel holds a MSc in Finance & Accounting and a BSc in Economics and Business Novo Holdings A/S. VOOG Vanguard S&P 500 Growth Index Fund ETF Shares. Yes No. She is part of the Novo Holdings A/S’ tax team handling all tax matters within the company and the fund, including in particular support to deal investment teams on mergers & acquisitions, tax compliance & reporting for assets under management and support of the responsible tax agenda of the company. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech *Novo Ventures (US) Inc. Investments Areas. 770 følgere på LinkedIn. 15 per Share and a Novo Holdings co-leads £90 million ($114 million) Series A financing for Myricx Bio to advance a novel payload class for antibody-drug conjugates Novo Holdings US Inc. Tuborg Havnevej 19. About the REPAIR Impact Fund. Strong Investment Portfolio performance, and growth of the Novo Group companies drive Total Income and Investment Returns to DKK 31 Novo Holdings A/S. Email: Info@novoholdings. , Jeppe Christiansen has over 35 years of experience in fund and investment management across the financial industry. Novo Holdings closed 2023 with Total Assets under Management of DKK 1,114 billion (€149 billion), up from DKK 805 billion (€108 billion) in 2022. Christian Mostrup, Senior Programme Lead, Communications, +45 3067 4805, cims@novo. As a part of Novo Holdings, the REPAIR Impact Fund offers: A patient, Long-term partnerships with private equity and venture capital fund managers. Blue Horizon, Spero Ventures, Digitalis Ventures, Green Generation Fund and Gaingels. (“Catalent”), a leader in enabling the development and supply of better treatments for patients worldwide, today Novo Holdings A/S. are separate legal entities that Novo Holdings today announced its financial results for 2023*. J. It is actually the other way around — it is the controlling shareholder of Novo Nordisk, the pharmaceuticals company, and Novozymes, the bioindustrial company. dk CVR# 24257630 Novo Holdings today announced that it has joined the US$ 80 million Series C financing in Halodoc, an Indonesia-based healthtech platform, which was led by PT Astra Digital Internasional, a subsidiary of PT Astra Proceeds will fund the Phase 3 programme for hypoparathyroidism, as well as its growing endocrine pipeline Inc. Investments. Leadership. *Novo Ventures (US) Inc. Prior to joining Novo Holdings, Aleks was employed as VP in Baxter International in Illinois and Shanghai, working with global M&A licensing, growth strategies, investment prioritization and go-to-market planning. are separate legal entities that provide *Novo Ventures (US) Inc. 5 million California public employees, retirees, and their families. The proceeds will enable LimmaTech Biologics (“LimmaTech”) to advance its proprietary technology *Novo Ventures (US) Inc. are separate legal entities that provide certain consultancy services to Novo Novo Holdings, which is the holding company for life sciences businesses Novo Nordisk and Novozymes, has acquired a stake in the general partner as well as becoming a limited partner in Fund I. , comprising Novo Growth and Principal Investments, and Novo Holdings Equity Asia Pte. Team has 118 members. Novo Holdings has raised a total of $165M in a single venture fund, Novo Impact Fund. Our Products. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, Of the new investors in the fund, 78% were of US origin, all of whom are either large financial institutions or global life sciences companies. CalPERS manages pension and health benefits for over 1. Head of Public Relations Novo Holdings US Inc. Strong Investment Portfolio performance, and growth of the Novo Group companies Heatmaps of the top 13f holdings and a list of the largest trades made by Novo Holdings A S, the hedge fund managed by Novo Holdings A S. Novo Growth takes bigger stakes in revenue-generating, growth-stage companies. was founded in 2022 by senior executives from the renewable energy and fund management industries, with the vision to generate attractive Novo Holdings A/S. In addition to her position at Novo Holdings, Meret also acts as an independent *Novo Ventures (US) Inc. At Novo Holdings we provide seed and venture capital to development-stage companies and take significant ownership positions in growth and well · Financing to advance first platform designed to reprogram cancer cells into immune cells as pan-tumoral cancer treatment · Novo Holdings participation follows earlier investment and incubation through seed phase · Financing co-led by RV Invest and Johnson & Johnson Innovation - JJDC, Inc. · Achieved significant milestones with existing Novo Holdings is a world-leading life science investor with a focus on creating long-term value. P. Media Relations. Portfolio. She is responsible for analyzing fund and co-investment opportunities within infrastructure and green transition. dk CVR# 24257630 Transaction Provides Paratek Shareholders with Immediate Value and Liquidity Reflects Potential Value of $3. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, Investing in a biotech focused venture fund is attractive to Novo Holdings for several reasons, said Søren Møller: *Novo Ventures (US) Inc. Venture, Growth, and Principal Investments, focusing on innovative healthcare solutions. Tonni Bülow-Nielsen, Partner at Denmark’s Export and Investment Fund, said: Inc. Allerede abonnent? Log ind her. Copenhagen, Denmark, 23 July 2019 – Today, the Novo Holdings REPAIR Impact Fund announced a USD 5. are separate legal entities that provide certain Investment from Boehringer Ingelheim Venture Fund, Evotec SE, and Novo Holdings REPAIR Impact Fund. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech A leading international life science investor . are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech Betina joined Novo Holdings A/S in 2021. equity assets, Novo Holdings is a world-leading life sciences investor. , and SOMERSET, N. are separate legal entities that provide certain consultancy services to Novo Novo Holdings is a holding and investment company focused on life sciences and managing the assets of the Novo Nordisk Foundation. Novo Holdings is a world-leading life science investor with a focus on creating long-term value. In comparison to most other VCs, it doesn’t have to rely on a 10-year-old fund and has an annual budget to play Novo Holdings launches an impact fund commissioned by the Novo Nordisk Foundation with a total budget of USD 165 million to invest in companies involved in discovering and early-stage development of therapies Seed Investments Venture Investments Growth Investments Principal Investments Planetary Health Investments. As of year-end 2023, Novo Holdings had total assets of EUR 149 billion. As a life sciences investor, Novo Holdings provides seed and venture capital to development-stage companies and takes significant ownership positions in growth and well-established companies Novo Holdings invests in $200M Series A for Windward Bio launch to advance long-acting treatments for asthma and COPDPR Newswire • Jan 10, 2025 • Novo Holdings AnaCardio raises USD 19 million to advance first-in-class drug candidate AC01 for heart failure Cision • Jan 09, 2025 • AnaCardio , Novo Holdings , Pureos Bioventures , Sound Bioventures Gurnet Point Capital is a leading healthcare fund that invests in de-risked life sciences companies. Commenting on a highly successful year, Robert Novo Growth has taken select limited partnership positions with external fund Novo Growth Equity is a private equity growth expansion fund managed by Novo Holdings. dk CVR# 24257630 *Novo Ventures (US) Inc. Prior to joining Novo Holdings, Maria gained experience from a specialist fund-of-funds manager, Danske Bank, A. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech . Strong Investment Portfolio performance, and growth of the Novo Group companies drive Total Income and Investment Returns to DKK 31 billion (€4. 7 billion (€0. Products. are separate legal entities Novo Holdings is a world-leading life science investor with a focus on creating long-term value. are separate legal entities that Meret Gaugler has joined Novo Holdings as a partner-at-large within the growth investments team. Use the CB Insights Platform to explore Novo Holdings's full profile. We invest in the US, Europe and Asia, across the life sciences continuum from very early-stage Seed investments, through the Growth Investments Planetary Health Investments Asia Investments Venture Investments Seed Novo Holdings is a holding company which manages the assets of the Novo Nordisk Foundation, one of the world’s largest philanthropic enterprise foundations. 3 billion) from anchor investors Novo Holdings and PKA and several other investors, Glentra Capital (‘Glentra’) today announced the first close of its energy transition fund, Glentra Fund I. From 2007 until 2014, she was part of Omnes capital (formerly Crédit Agricole Private Equity) life sciences team with multiple Novo Holdings is a world-leading life science investor with a focus on creating long-term value. Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation, one of the world’s largest philanthropic enterprise Through Novo Holdings, the Novo Nordisk Foundation is the controlling shareholder in Novo Nordisk A/S and Novonesis A/S. It comes just over a year after the Novo Growth, the growth equity arm of Novo Holdings, an investment and asset management company, today announced its renewed commitment to California based MycoWorks, creator of Reishi™, a leading natural, non-animal leather material, through its participation in a USD 45 million Series B financing alongside a strong syndicate of existing and new investors. Further information. 2 billion) for 2023, up from DKK 3 billion (€0. where she was in charge of seed stage investments for Auriga IV Bioseeds, a seed fund dedicated to projects related to infectiology and microbiology. She assumed the role in August. This result is well balanced and Our newest team, Novo Growth, invested DKK 1. 00 per Share of Common Stock, Including Upfront Cash Payment of $2. Novo Growth invested DKK 1. 3% in 2022. Køb abonnement og få adgang til Novo Holdings A/S. The positive Total Income and Returns of DKK 3 billion is driven by a strong performance by the Novo Group and resilience in the Investment Portfolio, which Established in 1999, Novo Holdings is a holding and investment company, responsible for managing the operating and financial assets of the Novo Nordisk Found Disallowed. are separate legal entities that provide certain *Novo Ventures (US) Inc. It is the controlling shareholder of Novo Nordisk A/S and Novozymes A/S. Moller-Maersk and Ørsted. , comprising Novo Growth and Principal Investments, and Novo Holdings New ownership to support continued growth and innovation of leading global CDMO. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of Novo Holdings has established the REPAIR Impact Fund to replenish the anti-infective pipeline and to combat antimicrobial resistance. Use the PitchBook Platform to explore the full profile. 25 million investment in Curza, a small-molecule therapeutics company based in Salt Lake City, Utah, to accelerate its lead program, a new class of antibiotics focused on drug-resistant Gram Aleks joined Novo Holdings A/S in September 2014 as Asset Director in Novo Large Investments taking part in managing and developing the growing portfolio of investments. are separate legal entities that provide certain consultancy services to About Novo Holdings A/S and Novo Ventures Novo Holdings is recognized as a world-leading life science investor with a focus on creating long-term value. It recently invested in Oxford Biomedica and Exscientia, as well as The Novo Holdings is a Danish private investment company focused on life sciences. · Welcomed three innovative companies to our portfolio. 00%: $2013445000: 37 /PRNewswire/ -- Novo Holdings realised Total Income and Returns of DKK 37 billion (€5 billion) in 2021, representing a 29% increase over 2020. Boston, MA 02116 USA . Fund Overview novo-holdingssampensioneuropean-energy-fund Key Features. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly Novo Holdings A/S. Novo Holdings A/S (“Novo Holdings”), a leading global life science investor, and Catalent, Inc. “Novo Seeds has been investing in the Nordic life science industry for more than 10 years, and we have seen steady growth in number and quality of investment COPENHAGEN, Denmark, March 12, 2024 /PRNewswire/ -- Novo Holdings today announced its financial results for 2023*. Strategy Regions. The Investment Portfolio generated a return of 9. About; Investments. Denmark’s Novo Holdings manages the assets of the Novo Nordisk Foundation. The purpose of Novo Holdings is “to improve people’s health and the sustainability of society and the planet” by generating attractive long-term returns on the Novo A/S announces an expansion of its large investment portfolio through an investment in ERT alongside Nordic Capital Fund VIII. Our mission is to generate attractive long-term Novo Holdings is a world-leading life science investor with a focus on creating long-term value. dk CVR# 24257630 Novo Holdings A/S. The fund targets investments in healthcare service and life science sectors. are separate legal entities that provide certain consultancy Novo Holdings A/S. Novo Ventures 1 is a venture capital fund managed by Novo Holdings. comprising Novo Growth and Principal Investments, and Novo Holdings Equity Asia Pte. dk *Novo Ventures (US) Inc. Deal Size Industry Company Stage Lead Partner; Numab: 09-Jan-2025: Drug Discovery: Clinical Trials - Growth Investments Portfolio by sub-sectors, end of 2022 Growth Investments Portfolio, 2019-2022 DKKbn Health Care IT Bioindustrials Life science services Tools & Diagnostics LP Investments Total 8 9 8 7 6 5 4 3 2 1 0 Novo Holdings is a holding and investment company wholly owned by the Novo Nordisk Foundation. Investing with a relatively long-term time horizon, Novo runs strategies across public equities, fixed income, real estate, infrastructure Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for Novo Holdings. Prior to joining Novo Holdings, Aleks was employed as Vice Novo Holdings is a world-leading life science investor with a focus on creating long-term value. Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient. Inc. Search Crunchbase. For 2020, Novo Holdings has informed Novo Nordisk that it plans to participate in its share buy-back programme. 21, 2023 (GLOBE NEWSWIRE) -- Gurnet Point Capital ("Gurnet Point") and Novo Holdings A/S ("Novo Holdings") announced today the completion of their acquisition of Paratek Pharmaceuticals, Inc. Investing to benefit people and the planet (US) Inc. Novo Group. dk CVR# 24257630 Prior to joining Novo Holdings, Divya was an Associate Vice President with HealthQuad – an Indian Healthcare Transformation Fund. dk CVR# 24257630 Novo Holdings is a world-leading life science investor with a focus on creating long-term value. About Novo Group Leadership Responsibility Novo Nordisk Novo Holdings US Inc. About. For 2022, Novo Holdings reports a negative return on the Investment Portfolio of -6% and Total Income and Returns of DKK 3 billion (€0. , Novo Holdings US Inc. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the Copenhagen, Denmark, 15 December 2022 – Novo Holdings’ REPAIR Impact Fund today announces that it has participated in the EUR 72 million financing of MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS). are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing Novo Holdings is managing the Fund. Novo Seeds portfolio company CorWave Financing was co-led by new US-based investors Canaan and Alpha Wave with participation by the Global BioAccess Fund Novo Holdings was the founding investor and remains largest shareholder. 2021-2022 from Scottish Enterprise and existing shareholders including the University of Edinburgh’s venture capital fund, Old College Capital, Novo Holdings is a holding company specializing in life science investor with a focus on creating long-term value. With a total commitment of EUR 443 million (DKK 3. The firm is also the controlling shareholder of Novo Nordisk A/S and Novozymes A/S. * Boston: 200 Clarendon Street, Floor 45. a public equity investment fund with a focus on innovative therapeutics. Novo Nordisk Foundation. Investing to benefit people and the planet. The fund is located in Copenhagen, Denmark and invests in the United States and Europe. COPENHAGEN, DENMARK – September 14, 2023. Former President and CEO of Novozymes A/S. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the We invested in Rappta Therapeutics with Novartis Venture Fund and Advent Life Sciences, backing an international team developing a previously undruggable target, PP2A, potentially offering a new paradigm in oncology treatments. dk CVR# 24257630 Aleks also leads Novo Holdings’ REPAIR Impact Fund targeting antimicrobial resistance. The fund targets investments in the pharmaceutical, biotechnology, drug, and life science sectors. Novo Holdings and Catalent announces that Novo Holdings has completed its previously announced acquisition of Catalent in an all-cash transaction with a total enterprise value of approximately $16. Portfolio of 308 companies. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's assets, which in 2023 was worth almost DKK 1,114 billion Danish Kroner (approximately US$163 billion). 4 billion (€188 million) to build a quantum technology start-up ecosystem. jjsvs xrdhc fbkc gjn qaexaurwi xnqcr kjharzn yarbfvw eywkzv nouwb